Giovanni Mariggi
InvestorCo-founder and Partner at Medicxi · Board director at Illexcor Therapeutics · Board director at FORE US Bio
Geneva
Find your path to Giovanni
490 people in our graph share verified history with Giovanni — schools, employers, funds. One of them is your warm intro.
About
Giovanni Mariggi co-founded a biotech venture firm after pioneering asset‑centric investing—concentrating teams around single high‑conviction drug assets—and takes a hands‑on vaccine company‑building role, chairing ViceBio and serving on Curevo's board.
Contact· self-published, not guessed
Invests in
BiotechDigital HealthHealthtechMedical Devices
Board director at Illexcor Therapeutics
Intro paths
In turn, Giovanni can intro founders to Illexcor Therapeutics's investors below.
Illexcor Therapeutics's investors · 2
Board director at FORE US Bio
Intro paths
In turn, Giovanni can intro founders to FORE US Bio's investors below.
Experience
- medicxiPartnercurrent2018 — presentLondon Area, United Kingdom
- medicxiPrincipal2016 — 2018London Area, United Kingdom
- Index VenturesPrincipal - Life Sciences2015 — 2016Geneva, Geneva, Switzerland
- Index VenturesAssociate - Life Sciences2012 — 2014Geneva, Geneva, Switzerland
- Cancer Research UKPhD Student2007 — 2011London Area, United Kingdom
- Deallus GroupConsultant2011London Area, United Kingdom
- Merck SeronoIndustry Placement2005 — 2006Geneva, Geneva, Switzerland
Skills & more
Languages English · French · Italian
From Giovanni's professional profile.
Deals · 4
Illexcor TherapeuticsBoard seat
via Medicxi · filed May 2026 · $69M raise
FORE US BioBoard seat
via Medicxi · filed May 2025 · $46M raise
CurevoLed round
via Medicxi · filed Mar 2025 · $84.8M raise
VicebioLed round
via Medicxi
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
AbivaxAura BiosciencesNew Amsterdam
Board seats
Breakpoint TherapeuticsForeBioVaderis Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Medicxi
Frequently asked questions
- Who is Giovanni Mariggi?
- Giovanni Mariggi co-founded a biotech venture firm after pioneering asset‑centric investing—concentrating teams around single high‑conviction drug assets—and takes a hands‑on vaccine company‑building role, chairing ViceBio and serving on Curevo's board.
- Where does Giovanni Mariggi work?
- Giovanni Mariggi is Co-founder and Partner at Medicxi and Board director at Illexcor Therapeutics and Board director at FORE US Bio.
- What does Giovanni Mariggi invest in?
- Giovanni Mariggi invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Giovanni Mariggi sit on?
- Giovanni Mariggi holds tracked board seats at Breakpoint Therapeutics, Curevo, FORE US Bio, ForeBio, Illexcor Therapeutics, Vaderis Therapeutics.
- What companies has Giovanni Mariggi invested in?
- Investments tracked here include Abivax, Aura Biosciences, Curevo, New Amsterdam, Vicebio.
- Where did Giovanni Mariggi go to school?
- Giovanni Mariggi studied at UCL (PhD, Biochemistry and Molecular Biology); Imperial College London (BSc with year in Industry, Biochemistry); Aiglon College (GCSEs & A-Levels).
- Does Giovanni Mariggi lead rounds?
- Yes — Giovanni Mariggi has led 5 tracked investments.
Same school
Also attended UCL657
+ 651 more
Shared employers
Also worked at medicxi26
+ 20 more
Also worked at Index Ventures133
+ 127 more
Also worked at Cancer Research UK33
+ 27 more
Also worked at Deallus Group7
+ 1 more